GioiaD, AloisioI, MazzolaGBifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants.Appl Microbiol Biotechnol.2014; 98: 563–77.
4.
SekirovI, RussellSL, AntunesLCGut microbiota in health and disease.Physiol Rev.2010; 90: 859–904.
HusebyeE, HellstromPM, MidtvedtT. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex.Dig Dis Sci.1994; 39: 946–56.
11.
HusebyeE, HellstromPM, SundlerFInfluence of microbial species on small intestinal myoelectric activity and transit in germ-free rats.Am J Physiol Gastrointest Liver Physiol.2001; 280: G368–80.
LeeYK, MazmanianSK. Has the microbiota played a critical role in the evolution of the adaptive immune system?Science.2010; 330: 1768–73.
14.
SatokariR, GrnroosT, LaitinenKBifidobacterium and lactobacillus DNA in the human placenta.Lett Appl Microbiol.2009; 48: 8–12.
15.
RautavaS, ColladoMC, SalminenSProbiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial.Neonatology.2012; 102: 178–84.
16.
JimenezE, FernandezL, MarinMLIsolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section.Curr Microbiol.2005; 51: 270–4.
17.
ArumugamM, RaesJ, PelletierEEnterotypes of the human gut microbiome.Nature.2011; 473: 174–80.
18.
KurokawaK, ItohT, KuwaharaTComparative metagenomics revealed commonly enriched gene sets in human Gut microbiomes;DNA RESEARCH.2007; 14: 169–81.
19.
WalkerAW, InceJ, DuncanSHDominant and diet-responsive groups of bacteria within the human colonic microbiota.ISME J.2011 Feb; 5(2): 220–30. Epub 2010 Aug 5.
20.
ZeX1, DuncanSH, LouisPRuminococcus bromii is a keystone species for the degradation of resistant starch in the human colon.ISME J.2012 Aug; 6(8): 1535–43. Epub 2012 Feb 16.
21.
ParkesGC, BrostoffJ, WhelanKGastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.Am J Gastroenterol.2008; 103: 1557–67.
NellS, SuerbaumS, JosenhansC. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.Nat Rev Microbiol.2010; 8: 564–77.
24.
SokolH, PigneurB, WatterlotLFaecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.Proc Natl Acad Sci USA.2008; 105: 16731–6.
25.
ArthurJC, Perez-ChanonaE, MuhlbauerMIntestinal inflammation targets cancer-inducing activity of the microbiota.Science.2012; 338: 120–3.
26.
ScanlanPD, ShanahanF, CluneYCulture independent analysis of the gut microbiota in colorectal cancer and polyposis.Environ Microbiol.2008; 10: 789–98.
27.
McLoughlinRM, MillsKH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma.J Allergy Clin Immunol.2011; 127: 1097–107.
28.
Abu-ShanabA, QuigleyEM. The role of the gut microbiota in nonalcoholic fatty liver disease.Nat Rev Gastroenterol Hepatol.2010; 7: 691–701.
29.
Henao-MejiaJ, ElinavE, JinCInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.Nature.2012; 482: 179–85.
KoethRA, WangZ, LevisonBSIntestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.Nat Med.2013; 19: 576–85.
32.
TurnbaughPJ, LeyRE, MahowaldMAAn obesity-associated gut microbiome with increased capacity for energy harvest.Nature.2006; 444: 1027–31.
33.
TurnbaughPJ, HamadyM, YatsunenkoTA core gut microbiome in obese and lean twins.Nature.2009; 457: 480–4.
34.
CaniPD, BibiloniR, KnaufCChanges in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice.Diabetes.2008; 57: 1470–81.
35.
WenL, LeyRE, VolchkovPYInnate immunity and intestinal microbiota in the development of Type 1 diabetes.Nature.2008; 455: 1109–13.
36.
MussoG, GambinoR, CassaderM. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.Annu Rev Med.2011; 62: 361–80.
37.
TurnbaughPJ, RidauraVK, FaithJJThe effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice.Sci Transl Med.2009Nov 11; 1(6): 614.
38.
NielsenS, NielsenDS, LauritzenLImpact of diet on the intestinal microbiota in 10-month-old infants.J Pediatr Gastroenterol Nutr.2007 May; 44(5): 613–8.
39.
AdlerCJ, DobneyK, WeyrichLSSequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions.Nat Genet.2013 Apr; 45(4): 450–5., 455e1. Epub 2013 Feb 17.
40.
WalkerAW, InceJ, DuncanSHDominant and diet-responsive groups of bacteria within the human colonic microbiota.ISME J.2011 Feb; 5(2): 220–30. Epub 2010 Aug 5.
41.
HumblotC, BruneauA, SutrenMBrussels sprouts, inulin and fermented milk alter the faecal microbiota of human microbiota-associated rats as shown by PCR-temporal temperature gradient gel electrophoresis using universal, Lactobacillus and Bifidobacterium 16S rRNA gene primers.Br J Nutr.2005 May; 93(5): 677–84.
42.
ParkarSG, RosendaleD, PaturiGIn vitro utilization of gold and green kiwifruit oligosaccharides by human gut microbial populations.Plant Foods Hum Nutr.2012 Sep; 67(3): 200–7.
43.
BeardsE1, TuohyK, GibsonG. A human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition.Br J Nutr.2010 Sep; 104(5): 701–8. Epub 2010 Apr 7.
44.
WaltonGE, LuC, TroghI, ArnautFA randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers.Nutr J.2012Jun 1; 11: 36.
45.
LisztK, ZwielehnerJ, HandschurMCharacterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE finger-printing.Ann Nutr Metab.2009; 54(4): 253–7. Epub 2009 Jul 27.
46.
IJssennaggerN, DerrienM, van DoornGMDietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk.PLoS One.2012; 7(12): e49868. Epub 2012 Dec 11.
47.
SanzY. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans.Gut Microbes.2010May-Jun;1(3): 135–7. Epub 2010 Mar 16.
48.
DonovanSM, WangM, LiMHost-microbe interactions in the neonatal intestine: role of human milk oligosaccharides.Adv Nutr.2012May 1; 3(3): 450S–5S.
SmithMI, YatsunenkoT, ManaryMJGut microbiomes of Malawian twin pairs discordant for kwashiorkor.Science.2013Feb 1; 339(6119): 548–54. Epub 2013 Jan 30.
51.
JaquetM, RochatI, MoulinJImpact of coffee consumption on the gut microbiota: a human volunteer study.Int J Food Microbiol.2009Mar 31; 130(2): 117–21. Epub 2009 Jan 23.
52.
MartinFP, RezziS, Peré-TrepatEMetabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects.J Proteome Res.2009 Dec; 8(12): 5568–79.
53.
CaniPD. Gutmicrobiota and obesity: lessons from the microbiome.Briefings In Functional Genomics.2013; 12(4): 381–7 (Advance Access publication date 24 April).
54.
LeyRE. Obesity and the human microbiome.Current Opinion in Gastroenterology.2010; 26: 5–11.
SchwiertzA, TarasD, SchaferKMicrobiota and SCFA in lean and overweight healthy subjects.Obesity.2009. doi: 10.1038/oby.2009.167. [Epub ahead of print].
57.
ColladoMC, IsolauriE, LaitinenKDistinct composition of gut microbiota during pregnancy in overweight and normal-weight women.Am J Clin Nutr.2008; 88: 894–9.
58.
SotosM, NadalI, MartiAGut microbes and obesity in adolescents.Proc Nutrition Soc.2008; 67: E20.
59.
DuncanSH, LobleyGE, HoltropGHuman colonic microbiota associated with diet, obesity and weight loss.Int J Obesity.2008; 32: 1720–4. J Pediatr (Rio J).2013.
60.
KalliomakiM, ColladoC, SalminenSEarly differences in fecal microbiota composition in children may predict overweight.Am J Clin Nutr.2008; 87: 534–8.
61.
SantacruzA, MarcosA, WarnbergJInterplay between weight loss and gut microbiota composition in overweight adolescents.Obesity;2009. doi: 10.1038/oby.2009.112 [Epub ahead of print].
62.
NadalI, SantacruzA, MarcosAShifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents.Int J Obesity.2009; 33: 758–67.
63.
SabateJ, JouetP, HarnoisFHigh prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.Obesity Surg.2008; 18: 371–7.
64.
ZhangH, DiBaiseJ, ZuccoloAHuman gut microbiota in obesity and after gastric bypass.Proc Natl Acad Sci USA.2009; 106: 2365–70.
65.
LeyRE, TurnbaughPJ, KleinSMicrobial ecology: human gut microbes associated with obesity.Nature.2006; 444: 1022–3.
66.
AngelakisE, ArmougomF, MillionMThe relationship between gut microbiota and weight gain in humans.Future Microbiol.2012 Jan; 7(1): 91–109.
67.
ArmougomF, HenryM, VialettesBMonitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients.PLoS ONE4(9), e7125(2009).
68.
MillionM, MaraninchiM, HenryMObesity-associated Gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.Int J Obesity.2011 [Epub ahead of print].
69.
ZuoHJ, XieZM, ZhangWWGut bacteria alteration in obese people and its relationship with gene polymorphism.World J Gastroenterol.2011: 17(8), 1076–81.
70.
BalamuruganR, GeorgeG, KabeerdossJQuantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children.Br J Nutr.2010; 103(3): 335–8 (2010).
71.
LarsenN, VogensenFK, van den BergFWGut microbiota in human adults with Type 2 diabetes differs from non-diabetic adults.PLoS ONE5(2), e9085(2010).
72.
BrownRK, Zehra-EsraI, Dae-WookKEffects of gut microbes on nutrient absorption and energy regulation.Nutr Clin Pract.2012April;27(2): 201–14. Published online 2012 February 24.
DusejaA, ChawlaYK. Obesity and NAFLD The Role of Bacteria and MicrobiotaClin Liver Dis.2014; 18:59–71.
75.
TsaiYT, ChengPC, PanTM. Anti-obesity effects of gut microbiota are associated with lactic acid bacteria.Appl Microbiol Biotechnol.2014; 98: 1–10.
76.
BackhedF, ManchesterJ, SemenkovichCMechanisms underlying the resistance to diet-induced obesity in germ-free mice.Proc Natl Acad Sci USA.2007; 104: 979–84.
77.
BackhedF, DingH, WangTThe gut microbiota as an environmental factor that regulates fat storage.Proc Natl Acad Sci USA.2004; 101: 15718–23.
78.
MandardS, ZandbergenF, van StratenEThe fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity.J Biol Chem.2006; 281: 934–44.
79.
YoonJC, ChickeringTW, RosenEDPeroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation.Mol Cell Biol.2000; 20: 5343–9.
80.
RomeoS, PennacchioL, FuYPopulation-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.Nat Genet.2007; 39: 513–6.
81.
StaigerH, HaasC, MachannJMuscle-derived angiopoietin-like protein 4 is induced by fatty acids via PPAR {delta} and is of metabolic relevance in humans.Diabetes.2008; 53: 579–89.
82.
KahnBB, AlquierT, CarlingDAMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.Cell Metab.2005; 1: 15–25.
83.
BrownAJ, GoldsworthySM, BarnesAAThe Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.J Biol Chem.2003; 278: 11312–9.
84.
Le PoulE, LoisonC, StruyfSFunctional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.J Biol Chem.2003; 278: 25481–9.
85.
SamuelBS, ShaitoA, MotoikeTEffects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41.Proc Natl Acad Sci USA.2008; 105: 16767–72.
CaniPD, NeyrinckAM, FavaFSelective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.Diabetologia.2007; 50: 2374–83.
88.
KimKA, GuW, LeeIAHigh fat diet induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway.PLoS One2012; 7: e47713.
89.
BelzerC, de VosWM. Microbes inside—from diversity to function: the case of Akkermansia.ISME J2012; 6: 1449–58.
90.
SantacruzA, ColladoMC, Garcia-ValdesLGut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.Br J Nutr.2010; 104: 83–92.
91.
HansenCH, KrychL, NielsenDSEarly life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse.Diabetologia.2012; 55: 2285–94.
92.
QinJ, LiY, CaiZA metagenome-wide association study of gut microbiota in type 2 diabetes.Nature.2012; 490: 55–60.
93.
CaniPD, PossemiersS, Van deWieleTChanges in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.Gut.2009; 58: 1091–103.
94.
de La SerreCB, EllisCL, LeeJPropensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation.Am J Physiol Gastrointest Liver Physiol.2010; 299: G440–8.
95.
AggarwalJ, SwamiG, KumarM. Probiotics and their effects on metabolic diseases: an update.J Clin Diagn Res.2013; 7: 173–7.
96.
Vijay-KumarM, AitkenJD, CarvalhoFAMetabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.Science.2010; 328: 228–31.
97.
TsukumoD, Carvalho-FilhoM, CarvalheiraJLoss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance.Diabetes.2007; 56: 1886–98.
98.
FeiN, ZhaoL. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice.ISME J.2013; 7: 880–4.
99.
MuccioliGG, NaslainD, BackhedFThe endocannabinoid system links gut microbiota to adipogenesis.Mol Syst Biol.2010; 6: 392.
100.
BurcelinR, SerminoM, ChaboCGut microbiota and diabetes: from pathogenesis to therapeutic perspective.Acta Diabetol.2011 Dec; 48(4): 257–73.
101.
AmarJ, BurcelinR, RuidavetsJEnergy intake is associated with endotoxemia in apparently healthy men.Am J Clin Nutr.2008; 87: 1219–23.
102.
FinkelsteinEA, TrogdonJG, JoelWAnnual medical spending attributable to obesity: payer- and service-specific Eestimates.Health Aff.2009; 28(5): w822-31. (Published online July 27, 2009; 10.1377/hlthaff.28.5.822).
103.
MaslowskiKM, VieiraAT, NgARegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.Nature.2009; 461: 1282–6.
104.
MarchesiJR, HolmesE, KhanFRapid and noninvasive metabonomic characterization of inflammatory bowel disease.J Proteome Res.2007; 6: 546–51.
105.
NeyrinckAM, DelzenneNM. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.Curr Opin Clin Nutr Metab Care.2010; 13: 722–8.
106.
CaniPD, DaubioulCA, ReusensBInvolvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.J Endocrinol.2005; 185: 457–65.
107.
CaniPD, KnaufC, IglesiasMAImprovement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagonlike peptide 1 receptor.Diabetes.2006; 55: 1484–90.
108.
DelmeeE, CaniPD, GualGRelation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice.Life Sci.2006; 79: 1007–13.
109.
MazmanianSK, KasperDL. The love-hate relationship between bacterial polysaccharides and the host immune system.Nat Rev Immunol.2006; 6: 849–58.
110.
ParnellJA, ReimerRA. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats.Br J Nutr.2012; 107: 601–13.
111.
CaniPD, NeyrinckAM, MatonNOligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.Obes Res.2005; 13: 1000–7.
112.
CaniPD, LecourtE, DewulfEMGut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal.Am J Clin Nutr.2009; 90: 1236–43.
113.
ParnellJA, ReimerRA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.Am J Clin Nutr.2009; 89: 1751–9.
114.
VerhoefSP, MeyerD, WesterterpKR. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake.Br J Nutr.2011; 106: 1757–62.
115.
NeyrinckAM, PossemiersS, VerstraeteWDietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.J Nutr Biochem.2012; 23: 51–9.
116.
DavisLM, MartinezI, WalterJBarcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans.PLoS One.2011; 6: 25200.
117.
AbramsSA, GriffinIJ, HawthorneKMEffect of prebiotic supplementation and calcium intake on body mass index.J Pediatr.2007; 151: 293–8.
118.
NeyrinckAM, PossemiersS, DruartCPrebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice.PLoS One.2011; 6: 20944.
119.
DaubioulCA, HorsmansY, LambertPEffects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.Eur J Clin Nutr.2005; 59: 723–6.
120.
DewulfEM, CaniPD, ClausSPInsight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women.Gut.2013; 62: 1112–21.
GoldenbergJZ, MaSS, SaxtonJD. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst.2013; Rev. 5: CD006095.
123.
BernardoWM, AiresFT, CarneiroRM.Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis.J Pediatr.2013; (Rio. J.)89: 18–24.
124.
MacklaimJM, CohenCR, DondersG.Exploringa road map to counter misconceptions about the cervicovaginal microbiome and disease.Reprod. Sci.2012; 19: 1154–62.
IsolauriE, RautavaS, SalminenS. Probiotics in the development and treatment of allergic disease.Gastroenterol. Clin North Am.2012; 41: 747–62.
127.
ErridgeC, AttinaT, SpickettCMA high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation.Am J Clin. Nutr.2007; 86: 1286–92.
128.
DelzenneNM, NeyrinckAM, BäckhedFTargeting gut microbiota in obesity: effects of prebiotics and probiotics.Nat Rev Endocrinol.2011Aug 9; 7(11): 639–46.
129.
AndreasenA. S.Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects.Br J Nutr.2010; 104: 1831–8.
130.
KadookaY, SatoM, ImaizumiKRegulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.Eur J Clin Nutr.2010; 64: 636–43.
131.
LuZX, WalkerKZ, MuirJG, DeaK. Arabinoxylan fibre improves metabolic control in people with type II diabetes.Eur J Clin Nutr.2004; 58: 621–8 (2004).
132.
GarciaAL, SteinigerJ, ReichSCArabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance.Horm Metab Res.2006; 38: 761–6.
133.
GarciaAL, OttoB, ReichSCArabinoxylan consumption decreases post-prandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.Eur J Clin Nutr.2007; 6: 334–41.
134.
ParnellJA, ReimerRA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.Am J Clin Nutr.2009; 89: 1751–9.
135.
LuoJ1, Van YperselleM, RizkallaSW, RossiF, BornetFR, SlamaG. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics.J Nutr.2000; 130: 1572–7.
136.
DaubioulCA, HorsmansY, LambertP, Danse E DelzenneNM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.Eur J Clin Nutr.2005; 59: 723–6.
137.
KelishadiR, FarajianS, SafaviMA randomized triple masked controlled trial on the effects of synbiotics on inflammation markers in overweight children.J Pediatr (Rio J).2013.
138.
RileyLW, RaphaelE, FaersteinE. Obesity in the United States - dysbiosis from exposure to low-dose antibiotics?Front Public Health.2013 Dec 19;1:69.
BarbaraG, StanghelliniV, Berti-CeroniCRole of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection.Aliment Pharmacol Ther.2000; 14: 1127–31.
142.
AthertonJC, BlaserMJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications.J Clin Invest.2009September 1; 119(9): 2475–87.
143.
FrancoisF, RoperJ, JosephNThe effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.BMC Gastroenterol.2011; 11: 37. Published online 2011 April 14.